The ASCENT project in the Philippines
The Philippines is one of the five countries where the ASCENT project is implemented. Over 90 health care facilities in the Bulacan Province, Pampanga Province and the National Capital Region are participating in the project. Patients and health care workers will make use of digital adherence technologies to support the former upon taking their daily TB medication at home, at work, or any venue of their choice. The first patients will be enrolled in 2020.
The Philippines has a population of 107 million people and is one of the 30 high TB burden countries in the world, as listed by the World Health Organization (WHO Global Tuberculosis Report,2019). In 2018, an estimated 591,000 people suffered from TB in the Philippines, giving a TB incidence rate of 554 per 100,000 population. An estimated 18,000 people suffered from multidrug-resistant TB. The WHO estimates 27,000 people died of TB in the Philippines.
news & Stories from the Philippines
German newspaper Die Zeit writes about TB and digital adherence technology
Dr. Jakob Simmank, the head of the health section of Die Zeit, an online newspaper in Hamburg, Germany, is preparing an article on the fight against tuberculosis (TB), including the use of digital adherence technology (DAT) for TB treatment.
Governor Fernando of Bulacan, Philippines signed MOU on World TB Day
Bulacan, Philippines celebrated World TB Day 2022 with Governor Daniel Fernando signing the Memorandum of understanding (MOU) between KNCV Tuberculosis Foundation and the Department of Health of the Philippines.
ASCENT hosted refresher courses in the Philippines for users of digital adherence technology
ASCENT Philippines gathered drug-resistant tuberculosis (DRTB) patients to guide them in their use of digital adherence technology (DAT), in particular video-supported treatment (VOT) using the SureAdhere app and the evriMED smart pillbox.
ASCENT Philippines boosts adherence support for tuberculosis patients
During a recent virtual meeting, key tuberculosis (TB) partners jointly reviewed and updated the ASCENT differentiated care pathway for the use of digital adherence technologies (DAT) to support TB patients taking their medication.